Rachel Brandstadter, MD

Articles by Rachel Brandstadter, MD

Pregnancy and Family Planning Considerations When Treating Patients With Multiple Sclerosis

ByStephen Krieger, MD,Rachel Brandstadter, MD,Riley Bove, MD

July 11th 2023

In this episode of MEDcast, Dr Krieger, Dr Brandstadter, and Dr Bove discuss MS care in patients who are considering pregnancy. They highlight treatment options, monitoring recommendations during and after pregnancy, as well as other crucial considerations when caring for patients with childbearing goals.

Pregnancy and Family Planning Considerations When Treating Multiple Sclerosis

ByStephen Krieger, MD,Rachel Brandstadter, MD,Riley Bove, MD

June 29th 2023

Generational Perspective in Multiple Sclerosis Care

ByStephen Krieger, MD,Rachel Brandstadter, MD,Fred Lublin, MD

June 23rd 2023

Dr Krieger, Dr Brandstadter, and Dr Lublin discuss the advances made in recognizing and managing multiple sclerosis over the last few decades and the challenges that remain.

Generational Perspectives in Multiple Sclerosis Care

ByStephen Krieger, MD,Rachel Brandstadter, MD,Fred Lublin, MD

June 14th 2023

Dr Krieger, Dr Brandstadter, and Dr Lublin discuss the advances made in recognizing and managing multiple sclerosis over the last few decades and the challenges that remain.

Evolution of Anti-CD20 Disease Modifying Therapies in Multiple Sclerosis - Recent Updates

ByStephen Krieger, MD,Rachel Brandstadter, MD,Lawrence Steinman, MD

June 9th 2023

In this episode of MEDcast, expert neurologists delve into anti-CD20 disease modifying therapies (DMTs) in MS. They assess the correlation between clinical observations and immunological processes in MS patients, and also examine the role of the Epstein Barr virus in MS.

Evolution of Anti-CD20 Disease Modifying Therapies in Multiple Sclerosis: Recent Updates

ByStephen Krieger, MD,Rachel Brandstadter, MD,Lawrence Steinman, MD

May 31st 2023

In this episode of MEDcast, expert neurologists delve into anti-CD20 disease-modifying therapies (DMTs) in MS. They assess the correlation between clinical observations and immunological processes in MS patients, and also examine the role of the Epstein Barr virus in MS. [LISTEN TIME: 48 minutes]